Literature DB >> 23257652

Transient Willis-Ekbom's disease (restless legs syndrome) during pregnancy may be caused by estradiol-mediated dopamine overmodulation.

José Carlos Pereira1, Ingrid Ramos Rocha e Silva, Márcia Pradella-Hallinan.   

Abstract

Willis-Ekbom's disease (WED), formerly called restless legs syndrome, is more common in pregnant than in non-pregnant women, implying that the physiological and biochemical changes during pregnancy influence its development. During pregnancy, many hormone levels undergo significant changes, and some hormones significantly increase in activity and can interfere with other hormones. For example, the steroid hormone estradiol interferes with the neuroendocrine hormone dopamine. During pregnancy, the activity of the thyroid axis is enhanced to meet the increased demand for thyroid hormones during this state. Dopamine is a neuroendocrine hormone that diminishes the levels of thyrotropin and consequently of thyroxine, and one of the roles of the dopaminergic system is to counteract the activity of thyroid hormones. When the activity of dopamine is not sufficient to modulate thyroid hormones, WED may occur. Robust evidence in the medical literature suggests that an imbalance between thyroid hormones and the dopaminergic system underpins WED pathophysiology. In this article, we present evidence that this imbalance may also mediate transient WED during pregnancy. It is possible that the main hormonal alteration responsible for transient WED of pregnancy is the excessive modulation of dopamine release in the pituitary stalk by estradiol. The reduced quantities of dopamine then cause decreased modulation of thyrotropin, leading to enhanced thyroid axis activity and subsequent WED symptoms. Iron deficiency may also be a predisposing factor for WED during pregnancy, as it can both diminish dopamine and increase thyroid hormone.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257652     DOI: 10.1016/j.mehy.2012.11.030

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

Review 1.  Restless legs syndrome and pregnancy: a review.

Authors:  Prachaya Srivanitchapoom; Sanjay Pandey; Mark Hallett
Journal:  Parkinsonism Relat Disord       Date:  2014-04-08       Impact factor: 4.891

2.  Pre-pregnancy restless legs syndrome (Willis-Ekbom Disease) is associated with perinatal depression.

Authors:  Jan Wesström; Alkistis Skalkidou; Mauro Manconi; Stephany Fulda; Inger Sundström-Poromaa
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

3.  17β-estradiol delays 6-OHDA-induced apoptosis by acting on Nur77 translocation from the nucleus to the cytoplasm.

Authors:  Justine Renaud; Keith Chiasson; Julie Bournival; Claude Rouillard; Maria-Grazia Martinoli
Journal:  Neurotox Res       Date:  2013-11-26       Impact factor: 3.911

Review 4.  Sleep disorders: A review of the interface between restless legs syndrome and iron metabolism.

Authors:  Paulo Daubian-Nosé; Miriam K Frank; Andrea Maculano Esteves
Journal:  Sleep Sci       Date:  2014-10-30

Review 5.  Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management.

Authors:  Shiyi Guo; Jinsha Huang; Haiyang Jiang; Chao Han; Jie Li; Xiaoyun Xu; Guoxin Zhang; Zhicheng Lin; Nian Xiong; Tao Wang
Journal:  Front Aging Neurosci       Date:  2017-06-02       Impact factor: 5.750

6.  Association between thyroid function and disease severity in restless legs syndrome.

Authors:  Chaofan Geng; Zhenzhen Yang; Xiumei Kong; Pengfei Xu; Hongju Zhang
Journal:  Front Neurol       Date:  2022-08-12       Impact factor: 4.086

7.  Restless Legs Syndrome, and symptoms of Restless Syndrome in patients with Graves' disease: a cross-sectional survey.

Authors:  Marcia Pradella-Hallinan; José Carlos Pereira; João Roberto Maciel Martins
Journal:  Clinics (Sao Paulo)       Date:  2020-11-11       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.